Advertisement

Der Internist pp 260-269 | Cite as

Hypertonie und Herz

  • B. E. Strauer
  • W. Motz
Chapter

Zusammenfassung

Die linksventrikuläre Herzmuskelhypertrophie mit der Gefahr einer Herzinsuffizienz stellt eine schwerwiegende Komplikation langdauernden erhöhten Blutdrucks dar. Der Beitrag geht auf ihre unterschiedlichen Formen, das heißt, die konzentrische, irreguläre und exzentrische Form ein, stellt dabei die Einflüsse des sympatho-adrenergen Systems, des Renin-Angiotensin- Aldo-steron-Systems und der genetischen Determination heraus und beschreibt die im Verlauf einer Herzhypertrophie sich abspielenden strukturellen Veränderungen am Myokard. Aus dem Stand der hypertensiven Herzkrankheit, ob mit oder ohne Symptome, resultiert eine entsprechende Differentialtherapie, die ebenfalls Gegenstand der Darstellung ist.

Schlüsselwörter

Myokardhyper-trophie Hypertrophieregression Antihypertensive Therapie Koronare Mikro- und Makroangiopathie 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Alcocer L, Aspe J (1979) The effect of antihypertensive treatment with alpha-methyldopa on left ventricular mass. In: Robertson JIS, Caldwell ADS (eds), Left ventricular hypertrophy in hypertension. Royal Society of Medicine, International Congress and Symposium Series, No. 9, Academic Press, London. Grune & Stratton, New York, pp 94–97Google Scholar
  2. 2.
    Bethge C, Motz W, Hehn v A, Strauer BE (1987) Ventricular arrhythmias in hypertensive heart disease with and without heart failure. J Cardiovasc Pharmacol 10 [Suppl C]: S119–S128Google Scholar
  3. 3.
    Bohn J, Rienmüller R, Seiderer M, Strauer BE (1983) Die nicht-invasive Bestimmung des enddiastolischen Volumens des linken Ventrikels. Eine vergleichende angiokardiographische, zweidimensional eeokardiographische, compu-tertomographische und radionuklidven-trikulographische Untersuchung. Z Kar-diol 72:438–447Google Scholar
  4. 4.
    Braunwald E (1984) Heart disease. Saunders, PhiladelphiaGoogle Scholar
  5. 5.
    Cooper G, IV, Marino TA (1984) Complete reversibility of cat right ventricular chronic progressive pressure overload. Circ Res 54:321–331CrossRefGoogle Scholar
  6. 6.
    Corea L, Bentivoglio M, Verdecchia P, Providenza M, Motolese M (1984) Left ventricular hypertrophy regression in hypertensive patients treated with meto-prolol. J Clin Pharmacol 22:363–370Google Scholar
  7. 7.
    Cutilletta AF, Dowell RT, Rudnik M, Areilla RA, Zak R (1975) Regression of myocardial hypertrophy. I. Experimental model, changes in heart weight, nucleic acids and collagen. J Mol Cell Card 7:767–781CrossRefGoogle Scholar
  8. 8.
    Deutsche Liga zur Bekämpfung des hohen Blutdrucks e.V. (1984) Empfehlungen zur Hochdruckbehandlung in der Praxis. MMW 45:130Google Scholar
  9. 9.
    Devereux RB, Savage DD, Drayer JIM, Laragh JH (1982) Left ventricular hypertrophy and function in high, normal and low-renin forms of essential hypertension. Hypertension 4:524–531PubMedCrossRefGoogle Scholar
  10. 10.
    Drayer JIM, Garding JM, Weber MS, Aronow WS (1983) Cardiac muscle mass during vasodilatation therapy of hypertension. Clin Pharmacol Ther 30:727–732CrossRefGoogle Scholar
  11. 11.
    Folkow B (1982): Physiological aspects of primary hypertension. Am Physiol Soc 62:347–504Google Scholar
  12. 12.
    Folkow B (1975) The Fourth Volhard Lecture. Cardiovascular structural adaption: its role in the initiation and maintance of primary hypertension. Clin Sci Mol Med 48:205s-214Google Scholar
  13. 13.
    Fouad FM, Nakashima Y, Tarazi RC, Salcedo EE (1982) Reversal of left ventricular hypertrophy in hypertensive patients treated with methyldopa. Lack with association with blood pressure control. Am J Cardiol 49:795–801PubMedCrossRefGoogle Scholar
  14. 14.
    Fouad FM, Shimamatsu K, Hanna MM, Khairallah PA, Tarazi RC (1985) Impaired inotropic responses to alphaadrenergic stimulation in experimental left ventricular hypertrophy. Circulation 71:1023–1028PubMedCrossRefGoogle Scholar
  15. 15.
    Ford EF (1985) Heart size. Circ Res 39:297–303Google Scholar
  16. 16.
    Franz IW, Wiewel D, Behr M, Ketelhut R (1986) Rückbildung der Myo-kardhypertrophieHochdruckkrankerunter chronischer β-Rezeptorenblockade. Dtsch Med Wochenschr 111:530–534PubMedCrossRefGoogle Scholar
  17. 17.
    Furuyama M (1962) Histometrical investigations of arteries in reference to arterial hypertension. Tokoku J Exp Med 76:388–314CrossRefGoogle Scholar
  18. 18.
    Grossmann W, Jones D, McLaurin LP (1975) Wall stress and patterns of hypertrophy in the human left ventricle. J Clin Invest 56:56–64CrossRefGoogle Scholar
  19. 19.
    Hess OM, Ritter M, Schneider J, Grimm K, Turina M, Krayenbühl HP (1984) Diastolic stiffness and myocardial structure in aortic valve disease before and after valve replacement. Circulation 69:865–885CrossRefGoogle Scholar
  20. 20.
    Ibrahim MM, Madakour MA, Massallani R (1981) Factors influencing cardiac hypertrophy in hypertensive patients. Clin Sci 61:105s–108sGoogle Scholar
  21. 21.
    James TH (1977) Small arteries of the heart. Circulation 56:2PubMedCrossRefGoogle Scholar
  22. 22.
    Kannel WB, Dawber TR (1973) Hypertensive cardiovascular disease. The Fra-mingham Study. In: Onesti G, Kim KE, Maya JH (eds) Hypertension: Mechanisms and management. Grune & Stratton, New York, pp 93Google Scholar
  23. 23.
    Kathke N (1955) Die Veränderungen der Koronararterienzweige des Myokards bei Hypertonie. Beitr Path Anat 155:405Google Scholar
  24. 24.
    Kaul U, Mohan JC, Bhatia ML (1984) Effects of labetalol on left ventricular lmass and function in hypertension — an assessment by serial echocardiography. J Cardiol 5:561–469Google Scholar
  25. 25.
    Lake CR, Ziegler MG, Coleman MD, Kopin IJ (1979) Hydrochlorthiazide-in-duced sympathetic hyperactivity in hypertensive patients. Clin Pharmacol Ther 26:428–432PubMedGoogle Scholar
  26. 26.
    Laks MN (1976) Norepinephrine — the myocardial hypertrophy hormone? Am Heart J 91:674–675PubMedCrossRefGoogle Scholar
  27. 27.
    McLenachan JM, Henderson E, Morris K, Dargie HJ (1987) Ventricular arrhythmias in patients with hypertensive left ventricular hypertrophy. N Engl J Med 317:787–792PubMedCrossRefGoogle Scholar
  28. 28.
    Motz W, Strauer BE (1984) Regression of structural cardiovascular changes by antihypertensive therapy. Hypertension 6:133–139CrossRefGoogle Scholar
  29. 29.
    Motz W, Ringsgwandl G, Strauer BE (1984) Regression of left ventricular muscle mass and collagen following nifedipine therapy. Circulation 70:237Google Scholar
  30. 30.
    Motz W, Strauer BE (1988) Rückbildung der hypertensiven Herzhypertrophie durch chronische Angiotensin-Kon-versionsenzymhemmung. Z Kardiol 77:53–60PubMedGoogle Scholar
  31. 31.
    Motz W, Klepzig M, Stellwaag M, Strauer BE (1987) Regression der Herzhypertrophie unter Saluretika? Klin Wo-chenschr 65 [Suppl 165]: 176Google Scholar
  32. 32.
    Motz W, Strauer BE (1988) Kalzium-Antagonisten in der Therapie der hyper-tensiven Herzhypertrophie: Vergleich von Nifedipin, Nitrendipin und Verapamil. (Zur Publikation eingereicht)Google Scholar
  33. 33.
    Muiesan G, Agabiti-Rosei E, Romanelli G, Muiesan ML, Castellano M, Beschi M (1986) Adrenergic activity and left ventricular function during treatment of essential hypertension with calcium antagonists. Am J Cardiol 57:44–49CrossRefGoogle Scholar
  34. 34.
    Nakashima Y, Fouad FM, Tarazi RC (1984) Regression of left ventricular hypertrophy from systemic hypertension by enalapril. Am J Cardiol 53:1044–1049PubMedCrossRefGoogle Scholar
  35. 35.
    Östman-Smith I (1981) Cardiac sympathetic nerves as the final common pathway in the induction of adaptive cardiac hypertrophy. Clin Sci 61:265–272PubMedGoogle Scholar
  36. 36.
    Riecker G (1982) Klinische Kardiologie. Krankheiten des Herzens, des Kreislaufs und der Gefäße. Springer, Berlin Heidelberg New YorkGoogle Scholar
  37. 37.
    Rowlands DB, Glover DR, Stallard TJ, Littler WA (1982) Control of blood pressure and reduction of echocardiographi-cally assessed left ventricular mass with once-daily timolol. Br J Clin Pharmacol 14:89–95PubMedCrossRefGoogle Scholar
  38. 38.
    Safar ME, Benessiano JR, Hornsky AL (1982) Asymmetric septal hypertrophy and borderline hypertension. Int J Cardiol 2:103–108PubMedCrossRefGoogle Scholar
  39. 39.
    Sau F, Seguro C, Merano G, Cherchi A (1986) Atenolol but not acebutolol reverses left ventricular hypertrophy secondary to arterial hypertension. J Am Coll Cardiol 7:186-AGoogle Scholar
  40. 40.
    Sen S, Tarazi RC, Bumpus FM (1979) Cardiac effects of angiotensin-antago-nists in normotensive rats. Clin Sci 56:439–444PubMedGoogle Scholar
  41. 41.
    Simpson P (1983) Norepineprine-stimu-lated hypertrophy of cultered rat myocardial cell is an alpha-1-adrenergic response. J Clin Invest 72:732–738PubMedCentralPubMedCrossRefGoogle Scholar
  42. 42.
    Strauer BE (1979) Myocardial oxygen consumption in chronic heart disease: role of wall stress, hypertrophy and coronary reserve. Am J Cardiol 44:730–740PubMedCrossRefGoogle Scholar
  43. 43.
    Strauer BE (1980) Ventricular function and coronary hemodynamics in hypertensive heart disease. Am J Cardiol 44:999–1006CrossRefGoogle Scholar
  44. 44.
    Strauer BE (1983) Hypertensive heart disease. Springer, Berlin Heidelberg New YorkGoogle Scholar
  45. 45.
    Strauer BE (1983) Das Hochdruckherz, 2. Aufl. Springer, Berlin Heidelberg New YorkCrossRefGoogle Scholar
  46. 46.
    Strauer BE, Mahmoud MA, Bayer F, Bohn J, Motz U (1984) Reversal of left ventricular hypertrophy and improvement of cardiac function in man by nifedipine. Eur Heart J 5 [Suppl F]: 53–60PubMedCrossRefGoogle Scholar
  47. 47.
    Strauer BE, Bayer F, Brecht HM, Motz W (1985) The influence of sympathetic nervous activity on regression of cardiac hypertrophy. J Hypertension 3 [Suppl4]:S39–S44Google Scholar
  48. 48.
    Strauer BE (1985) Progression und Regression der Herzhypertrophie beim arteriellen Bluthochdruck: Pathophysiologie und Klinik. Z Kardiol 74 [Suppl 7]: 171–178PubMedGoogle Scholar
  49. 49.
    Tarazi RC, Sen S, Saragoca M, Kairrallah P (1982) The multifactorial role of catecholamines in hypertensive cardiac hypertrophy. Eur Heart J 3 [Suppl A]: A-103PubMedCrossRefGoogle Scholar
  50. 50.
    Tarazi RC, Fouad FM (1984) Reversal of cardiac hypertrophy in man. Hypertension 6:140–146CrossRefGoogle Scholar
  51. 51.
    Thiedemann KU, Holubarsch C, Medugorac I, Jacob R (1983) Connective tissue content and myocardial stiffness in pressure overload hypertrophy. A combined study of morphologic, morphome-tric, biochemical, and mechanical parameters. Basic Res Cardiol 78:140–155PubMedCrossRefGoogle Scholar
  52. 52.
    Wallace JM (1975) Hemodynamic lesions in hypertension. Am J Cardiol 36:670PubMedCrossRefGoogle Scholar
  53. 53.
    Wikstrand, Trimarcoo B, Buzzetti G, Ricciardelli B, De Luca N, Volpe M, Condorelli M (1983) Increased cardiac output and lowered peripheral resistance during metoprolol treatment. Acta Med Scand [Suppl] 672:105–110Google Scholar
  54. 54.
    Wikstrand J, Trimarco B, Ricciardelli B, De Luca N, Volope M (1984) Reversal of cardiovascular changes during antihypertensive treatment: functional consequences and time course of reversal as judged from clinical studies. Hypertension 6:348–367CrossRefGoogle Scholar
  55. 55.
    Wollam GL, Hall DW, Porter VD, Douglas MB, Unger DJ, Blumenstein BA, Cotsonis GA, Knudtson ML, Feiner JM, Schlant RC (1983) Time course of regression of left ventricular hypertrophy in treated hypertensive patients. Am J Med S 100–110Google Scholar
  56. 56.
    World Health Organisation (1962) Hypertension and coronary heart disease: classification and criteria for epidemiological studies. First Report of the Expert Committee on Cardiovascular Diseases and Hypertension. Techn Rep Sci, p 168Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1988

Authors and Affiliations

  • B. E. Strauer
    • 1
    • 2
  • W. Motz
    • 1
    • 2
  1. 1.Abteilung für Kardiologie, Pneumologie und Angiologie der Medizinischen Klinik und PoliklinikUniversität DüsseldorfDeutschland
  2. 2.Abteilung für Kardiologie, Pneumologie und Angiologie Medizinischen Klinik und PoliklinikUniversität DüsseldorfDüsseldorf 1Deutschland

Personalised recommendations